Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trametinib for Complicated Vascular Anomalies
NCT07072403Phase 2Active, not recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in Vascular anomalies, sponsored by West China Hospital of Sichuan University. Started Jul 2025; status: active, not recruiting.
02
Drugs
trametinib
03
Conditions
Vascular anomalies
Beyond the preview
Go deeper on NCT07072403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07072403.